Overview


According to FutureWise analysis the market for radiosurgery systems in 2023 is US$ 2.4 billion, and is expected to reach US$ 4.1 billion by 2031 at a CAGR of 6.9%.

Radiosurgery, also known as stereotactic radiosurgery, is a very precise form of therapeutic radiology. Despite being called surgery, radiosurgery does not involve actual surgery. To treat cancerous tissues, focused beams of radiation (gamma rays, X-rays, or protons) are used instead of surgical incisions. A radiosurgery treatment is a one-session radiation therapy treatment that creates similar results to a surgical procedure. An example of radiosurgery is the destruction of precisely selected tissue using ionizing radiation rather than excision with a blade. This form of radiation therapy is usually used to treat cancer, like other forms of radiation therapy. The Swedish neurosurgeon Lars Leksell originally defined radiosurgery as "a single high-dose fraction of radiation stereotactically directed to an intracranial region of interest". An external radiation therapy called radiosurgery uses special devices to position the patient so that a large dose of radiation can be delivered precisely to the tumor. In spite of the fact that radiosurgery is called surgery, it does not involve any surgical procedures. For the treatment of cancerous tissues, highly focused beams of radiation (gamma rays, X-rays, or protons) are used instead of surgical incisions or openings. In addition to destroying tumor cells' DNA, it also prevents their reproduction and growth. A precise form of radiation therapy, stereotactic radiosurgery is also known as stereotactic radiosurgery. Radiosurgery is required to treat malignant or benign tumors in conditions such as brain tumors, spine tumors, and cancer. Radiosurgery systems include gamma knife systems, linear accelerator systems, and proton beam systems. Using radio waves, radiosurgery destroys selected areas of the tissue with the help of radiation. There are two types of radiosurgery: stereotactic radiosurgery and staged radiosurgery. With stereotactic radiosurgery, the radiation is directed at the exact target, and with staged radiosurgery, the radiation is delivered over a certain period of time with smaller doses. Various types of cancer and tumors can be treated with radiosurgery. Approximately 50% of cancer patients are treated with radiosurgery, according to the National Cancer Institute (NCI). The use of advanced robotics, tumor tracking, and imaging capabilities in radiosurgery makes treatment and surgery easier for healthcare providers. Elekta introduced a new concept of treating any brain target virtually with the Leksell Gamma Knife Icon device. Ultra-precise micro radiosurgery is possible with this device.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Radiosurgery Systems Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Radiosurgery Systems Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • ACCURAY INCORPORATED
  • ELEKTA AB
  • Atrium Health
  • Avocure
  • Brainlab
  • Integra LifeSciences Holding Corp
  • Ion Beam Applications SA
  • Medtronic
  • Mevion Medical Sytems Inc
  • Nordion Inc
  • RefleXion Medical
  • Siemens
  • Summit Cancer Centers
  • ViewRay
  • Vision rt Ltd
  • Xcision Medical Systems
  • ZAP Surgical System Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Linear Accelerator Systems
  • Proton Beam therapy
  • Gamma Knife System

By Condition

  • Brain Tumors
    • Malignant
    • NonMalignant
  • Spine Tumors

By End-User

  • Hospitals
  • Academic and Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Radiosurgery Systems Market By Type, By Condition, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Radiosurgery Systems Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Radiosurgery Systems Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Radiosurgery Systems Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Radiosurgery Systems Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Linear Accelerator Systems
        2. Proton Beam therapy
        3. Gamma Knife System

  • 8.   Radiosurgery Systems Market, By Condition Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Brain Tumors
         1.1. Maligant
         1.2. NonMalignant
        2. Spine Tumors

  • 9.   Radiosurgery Systems Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Academic and Research Institutes

  • 10.   North America Radiosurgery Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Radiosurgery Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Radiosurgery Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Radiosurgery Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. ACCURAY INCORPORATED
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. ELEKTA AB
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Atrium Health
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Avocure
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Brainlab
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Integra LifeSciences Holding Corp
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Ion Beam Applications SA
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Medtronic
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Mevion Medical Sytems Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Nordion Inc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. RefleXion Medical
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Siemens
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Summit Cancer Centers
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. ViewRay
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Vision rt Ltd
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
         16. Xcision Medical Systems
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. ZAP Surgical System Inc
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients